{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T14:27:15Z","timestamp":1794320835104,"version":"4.9.0"},"reference-count":400,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.metabol.2021.154910","type":"journal-article","created":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T16:55:31Z","timestamp":1633712131000},"page":"154910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":195,"special_numbering":"C","title":["Heart failure in diabetes"],"prefix":"10.1016","volume":"125","author":[{"given":"Stanislovas S.","family":"Jankauskas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urna","family":"Kansakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahimeh","family":"Varzideh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Mone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Gambardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Santulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2021.154910_bb0005","first-page":"pvab069","article-title":"Advances in the understanding of excitation-contraction coupling: the pulsing quest for drugs against heart failure and arrhythmias","author":"Kansakar","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.metabol.2021.154910_bb0010","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1126\/science.3704638","article-title":"Relation between work and phosphate metabolite in the in vivo paced mammalian heart","volume":"232","author":"Balaban","year":"1986","journal-title":"Science."},{"key":"10.1016\/j.metabol.2021.154910_bb0015","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012731","article-title":"Complex regulation of mitochondrial function during cardiac development","volume":"8","author":"Zhao","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.metabol.2021.154910_bb0020","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.00081.2018","article-title":"Propionate-induced changes in cardiac metabolism, notably CoA trapping, are not altered by l-carnitine","volume":"315","author":"Wang","year":"2018","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2021.154910_bb0025","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/s42255-020-00288-1","article-title":"Mitochondrial pyruvate carriers are required for myocardial stress adaptation","volume":"2","author":"Zhang","year":"2020","journal-title":"Nat Metab"},{"key":"10.1016\/j.metabol.2021.154910_bb0030","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.yjmcc.2019.07.007","article-title":"Remodeling of substrate consumption in the murine sTAC model of heart failure","volume":"134","author":"Turer","year":"2019","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.metabol.2021.154910_bb0035","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.2337\/dbi20-0024","article-title":"Metabolic flexibility of mitochondria plays a key role in balancing glucose and fatty acid metabolism in the diabetic heart","volume":"69","author":"Gambardella","year":"2020","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2021.154910_bb0040","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1152\/physrev.00006.2004","article-title":"Myocardial substrate metabolism in the normal and failing heart","volume":"85","author":"Stanley","year":"2005","journal-title":"Physiol Rev"},{"key":"10.1016\/j.metabol.2021.154910_bb0045","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/0002-9343(54)90365-4","article-title":"Metabolism of the human heart. II. Studies on fat, ketone and amino acid metabolism","volume":"16","author":"Bing","year":"1954","journal-title":"Am J Med"},{"key":"10.1016\/j.metabol.2021.154910_bb0050","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/CIRCULATIONAHA.115.017355","article-title":"The failing heart relies on ketone bodies as a fuel","volume":"133","author":"Aubert","year":"2016","journal-title":"Circulation."},{"key":"10.1016\/j.metabol.2021.154910_bb0055","article-title":"Ketone metabolism in the failing heart","volume":"1865","author":"Lopaschuk","year":"2020","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.metabol.2021.154910_bb0060","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","article-title":"Cardiac energy metabolism in heart failure","volume":"128","author":"Lopaschuk","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2021.154910_bb0065","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1042\/bj1240475","article-title":"Effects of increased heart work on glycolysis and adenine nucleotides in the perfused heart of normal and diabetic rats","volume":"124","author":"Opie","year":"1971","journal-title":"Biochem J"},{"key":"10.1016\/j.metabol.2021.154910_bb0070","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1172\/JCI112820","article-title":"Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans","volume":"79","author":"Wisneski","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2021.154910_bb0075","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1900\/RDS.2006.3.108","article-title":"Causes and characteristics of diabetic cardiomyopathy","volume":"3","author":"Wang","year":"2006","journal-title":"Rev Diabet Stud"},{"key":"10.1016\/j.metabol.2021.154910_bb0080","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.metabol.2014.08.010","article-title":"Diabetic dyslipidemia","volume":"63","author":"Wu","year":"2014","journal-title":"Metabolism."},{"key":"10.1016\/j.metabol.2021.154910_bb0085","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.numecd.2017.05.011","article-title":"Opposite effects of beta2-adrenoceptor gene deletion on insulin signaling in liver and skeletal muscle","volume":"27","author":"Cipolletta","year":"2017","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.metabol.2021.154910_bb0090","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s12265-014-9545-9","article-title":"Impact of diabetes mellitus on the clinical response to cardiac resynchronization therapy in elderly people","volume":"7","author":"Sardu","year":"2014","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.metabol.2021.154910_bb0095","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1172\/JCI115842","article-title":"Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension","volume":"90","author":"Lembo","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2021.154910_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/cells10010167","article-title":"The metabolic role of GRK2 in insulin resistance and associated conditions","volume":"10","author":"Sorriento","year":"2021","journal-title":"Cells."},{"key":"10.1016\/j.metabol.2021.154910_bb0105","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1161\/CIRCULATIONAHA.110.988642","article-title":"G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia","volume":"123","author":"Ciccarelli","year":"2011","journal-title":"Circulation."},{"key":"10.1016\/j.metabol.2021.154910_bb0110","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s12265-020-10057-w","article-title":"Modulation of insulin sensitivity by exercise training: implications for cardiovascular prevention","volume":"14","author":"Iaccarino","year":"2021","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.metabol.2021.154910_bb0115","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jacc.2005.09.030","article-title":"Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus","volume":"47","author":"Herrero","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2021.154910_bb0120","doi-asserted-by":"crossref","first-page":"E452","DOI":"10.1152\/ajpendo.00437.2015","article-title":"Assessment of myocardial metabolic flexibility and work efficiency in human type 2 diabetes using 16-[18F]fluoro-4-thiapalmitate, a novel PET fatty acid tracer","volume":"310","author":"Mather","year":"2016","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2021.154910_bb0125","doi-asserted-by":"crossref","first-page":"7850","DOI":"10.1111\/jcmm.15418","article-title":"FOXO1 contributes to diabetic cardiomyopathy via inducing imbalanced oxidative metabolism in type 1 diabetes","volume":"24","author":"Yan","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.metabol.2021.154910_bb0130","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.yjmcc.2019.02.012","article-title":"Adropin treatment restores cardiac glucose oxidation in pre-diabetic obese mice","volume":"129","author":"Thapa","year":"2019","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.metabol.2021.154910_bb0135","doi-asserted-by":"crossref","first-page":"1905194","DOI":"10.1155\/2019\/1905194","article-title":"Diabetes mellitus and its cardiovascular complications: new insights into an old disease","volume":"2019","author":"Sardu","year":"2019","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.metabol.2021.154910_bb0140","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jacbts.2018.07.006","article-title":"Empagliflozin increases cardiac energy production in Diabetes: novel translational insights into the heart failure benefits of SGLT2 inhibitors","volume":"3","author":"Verma","year":"2018","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.metabol.2021.154910_bb0145","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1242\/jcs.041178","article-title":"A common trafficking route for GLUT4 in cardiomyocytes in response to insulin, contraction and energy-status signalling","volume":"122","author":"Fazakerley","year":"2009","journal-title":"J Cell Sci"},{"key":"10.1016\/j.metabol.2021.154910_bb0150","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1006\/bbrc.1995.2164","article-title":"Insulin-dependent regulation of Glut4 gene expression in ventricular cardiomyocytes: evidence for a direct effect on Glut4 transcription","volume":"213","author":"Petersen","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2021.154910_bb0155","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1210\/endo.142.12.8555","article-title":"The endosomal compartment is an insulin-sensitive recruitment site for GLUT4 and GLUT1 glucose transporters in cardiac myocytes","volume":"142","author":"Becker","year":"2001","journal-title":"Endocrinology."},{"key":"10.1016\/j.metabol.2021.154910_bb0160","doi-asserted-by":"crossref","first-page":"7085","DOI":"10.1074\/jbc.272.11.7085","article-title":"Insulin-induced recruitment of glucose transporter 4 (GLUT4) and GLUT1 in isolated rat cardiac myocytes. Evidence of the existence of different intracellular GLUT4 vesicle populations","volume":"272","author":"Fischer","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2021.154910_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146033","article-title":"Diabetes alters the expression and translocation of the insulin-sensitive glucose transporters 4 and 8 in the Atria","volume":"10","author":"Maria","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2021.154910_bb0170","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007159","article-title":"Cardiac insulin signaling regulates glycolysis through phosphofructokinase 2 content and activity","volume":"6","author":"Bockus","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.metabol.2021.154910_bb0175","doi-asserted-by":"crossref","first-page":"48085","DOI":"10.1074\/jbc.M405510200","article-title":"Cardiac expression of kinase-deficient 6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatase inhibits glycolysis, promotes hypertrophy, impairs myocyte function, and reduces insulin sensitivity","volume":"279","author":"Donthi","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2021.154910_bb0180","doi-asserted-by":"crossref","first-page":"13274","DOI":"10.1016\/S0021-9258(19)38648-X","article-title":"Role of fructose 2,6-bisphosphate in the control of heart glycolysis","volume":"268","author":"Depre","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2021.154910_bb0185","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12933-020-01177-3","article-title":"Insulin directly stimulates mitochondrial glucose oxidation in the heart","volume":"19","author":"Karwi","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.metabol.2021.154910_bb0190","doi-asserted-by":"crossref","first-page":"10162","DOI":"10.1074\/jbc.M115.705608","article-title":"FoxO1 deacetylation decreases fatty acid oxidation in beta-cells and sustains insulin secretion in Diabetes","volume":"291","author":"Kim-Muller","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2021.154910_bb0195","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/s41467-019-09418-0","article-title":"FoxK1 and FoxK2 in insulin regulation of cellular and mitochondrial metabolism","volume":"10","author":"Sakaguchi","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2021.154910_bb0200","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00838.2020","article-title":"FoxO1 is required for physiological cardiac hypertrophy induced by exercise but not by constitutively active PI3K","volume":"320","author":"Weeks","year":"2021","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.metabol.2021.154910_bb0205","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009191","article-title":"Insulin receptor signaling in normal and insulin-resistant states","volume":"6","author":"Boucher","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.metabol.2021.154910_bb0210","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nm.4350","article-title":"Insulin action and resistance in obesity and type 2 diabetes","volume":"23","author":"Czech","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2021.154910_bb0215","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.00097.2018","article-title":"Cardiac branched-chain amino acid oxidation is reduced during insulin resistance in the heart","volume":"315","author":"Fillmore","year":"2018","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2021.154910_bb0220","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.cardiores.2003.11.021","article-title":"Initial steps of insulin signaling and glucose transport are defective in the type 2 diabetic rat heart","volume":"61","author":"Desrois","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.metabol.2021.154910_bb0225","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1172\/JCI60329","article-title":"Metabolic stress-induced activation of FoxO1 triggers diabetic cardiomyopathy in mice","volume":"122","author":"Battiprolu","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2021.154910_bb0230","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12872-018-0943-9","article-title":"The association between diabetes mellitus and reduction in myocardial glucose uptake: a population-based (18)F-FDG PET\/CT study","volume":"18","author":"Hu","year":"2018","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.metabol.2021.154910_bb0235","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0735-1097(03)00914-8","article-title":"Insulin ameliorates exercise ventilatory efficiency and oxygen uptake in patients with heart failure-type 2 diabetes comorbidity","volume":"42","author":"Guazzi","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2021.154910_bb0240","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1161\/CIRCRESAHA.118.314607","article-title":"Mitophagy is essential for maintaining cardiac function during high fat diet-induced diabetic cardiomyopathy","volume":"124","author":"Tong","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2021.154910_bb0245","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1172\/JCI99315","article-title":"Endothelial cell CD36 optimizes tissue fatty acid uptake","volume":"128","author":"Son","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2021.154910_bb0250","article-title":"Alterations in fatty acid metabolism and sirtuin signaling characterize early type-2 diabetic hearts of fructose-fed rats","volume":"5","author":"Lou","year":"2017","journal-title":"Phys Rep"},{"key":"10.1016\/j.metabol.2021.154910_bb0255","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.7150\/thno.40735","article-title":"Distinct cardiac energy metabolism and oxidative stress adaptations between obese and non-obese type 2 diabetes mellitus","volume":"10","author":"Li","year":"2020","journal-title":"Theranostics."},{"issue":"1119\u201334","key":"10.1016\/j.metabol.2021.154910_bb0260","article-title":"Glycogen synthase kinase-3alpha promotes fatty acid uptake and Lipotoxic cardiomyopathy","volume":"29","author":"Nakamura","year":"2019","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2021.154910_bb0265","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12933-019-0811-7","article-title":"MiR-30c\/PGC-1beta protects against diabetic cardiomyopathy via PPARalpha","volume":"18","author":"Yin","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.metabol.2021.154910_bb0270","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1159\/000492091","article-title":"High fat diet upregulates fatty acid oxidation and Ketogenesis via intervention of PPAR-gamma","volume":"48","author":"Sikder","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.metabol.2021.154910_bb0275","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.mito.2019.07.009","article-title":"Upregulated PDK4 expression is a sensitive marker of increased fatty acid oxidation","volume":"49","author":"Pettersen","year":"2019","journal-title":"Mitochondrion."},{"key":"10.1016\/j.metabol.2021.154910_bb0280","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1161\/01.CIR.0000026392.80723.DC","article-title":"Downregulation of myocardial myocyte enhancer factor 2C and myocyte enhancer factor 2C-regulated gene expression in diabetic patients with nonischemic heart failure","volume":"106","author":"Razeghi","year":"2002","journal-title":"Circulation."},{"key":"10.1016\/j.metabol.2021.154910_bb0285","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/cvr\/cvu156","article-title":"Obesity-induced lysine acetylation increases cardiac fatty acid oxidation and impairs insulin signalling","volume":"103","author":"Alrob","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.metabol.2021.154910_bb0290","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3389\/fendo.2018.00642","article-title":"Chronic O-GlcNAcylation and diabetic cardiomyopathy: the bitterness of glucose","volume":"9","author":"Ducheix","year":"2018","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.metabol.2021.154910_bb0295","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/CIRCRESAHA.110.224675","article-title":"O-GlcNAc signaling in the cardiovascular system","volume":"107","author":"Ngoh","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2021.154910_bb0300","doi-asserted-by":"crossref","first-page":"14074","DOI":"10.1021\/acs.jafc.9b05706","article-title":"Ginsenoside-Rb1 improved diabetic cardiomyopathy through regulating calcium signaling by alleviating protein O-GlcNAcylation","volume":"67","author":"Qin","year":"2019","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.metabol.2021.154910_bb0305","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.2337\/db19-1057","article-title":"Maintaining myocardial glucose utilization in diabetic cardiomyopathy accelerates mitochondrial dysfunction","volume":"69","author":"Wende","year":"2020","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2021.154910_bb0310","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1089\/ars.2019.7803","article-title":"Metabolic responses to reductive stress","volume":"32","author":"Xiao","year":"2020","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.metabol.2021.154910_bb0315","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1038\/srep05189","article-title":"Metabolic engineering of lactate dehydrogenase rescues mice from acidosis","volume":"4","author":"Acharya","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2021.154910_bb0320","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/gb-2004-5-5-224","article-title":"Sirtuins: Sir2-related NAD-dependent protein deacetylases","volume":"5","author":"North","year":"2004","journal-title":"Genome Biol"},{"key":"10.1016\/j.metabol.2021.154910_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10030338","article-title":"Sirt1 and Sirt3 activation improved cardiac function of diabetic rats via modulation of mitochondrial function","volume":"10","author":"Paramesha","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.metabol.2021.154910_bb0330","doi-asserted-by":"crossref","first-page":"10872","DOI":"10.1096\/fj.201900767R","article-title":"The nuclear and mitochondrial sirtuins, Sirt6 and Sirt3, regulate each other\u2019s activity and protect the heart from developing obesity-mediated diabetic cardiomyopathy","volume":"33","author":"Kanwal","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.metabol.2021.154910_bb0335","article-title":"Epigenetic regulation associated with Sirtuin 1 in complications of Diabetes mellitus","volume":"11","author":"Wang","year":"2020","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.metabol.2021.154910_bb0340","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/cvr\/cvv183","article-title":"Mitochondrial complex I defect and increased fatty acid oxidation enhance protein lysine acetylation in the diabetic heart","volume":"107","author":"Vazquez","year":"2015","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.metabol.2021.154910_bb0345","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.2337\/db13-0880","article-title":"Glucose-6-phosphate-mediated activation of liver glycogen synthase plays a key role in hepatic glycogen synthesis","volume":"62","author":"von Wilamowitz-Moellendorff","year":"2013","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2021.154910_bb0350","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/iub.1017","article-title":"Glucose-6-phosphate dehydrogenase, NADPH, and cell survival","volume":"64","author":"Stanton","year":"2012","journal-title":"IUBMB Life"},{"key":"10.1016\/j.metabol.2021.154910_bb0355","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3389\/fendo.2020.00365","article-title":"The role of the pentose phosphate pathway in diabetes and cancer","volume":"11","author":"Ge","year":"2020","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.metabol.2021.154910_bb0360","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/cvr\/cvs291","article-title":"Boosting the pentose phosphate pathway restores cardiac progenitor cell availability in diabetes","volume":"97","author":"Katare","year":"2013","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.metabol.2021.154910_bb0365","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012673","article-title":"Glucose metabolism in cardiac hypertrophy and heart failure","volume":"8","author":"Tran","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.metabol.2021.154910_bb0370","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.freeradbiomed.2021.03.046","article-title":"Therapeutic potential of targeting oxidative stress in diabetic cardiomyopathy","volume":"169","author":"Byrne","year":"2021","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.metabol.2021.154910_bb0375","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.yjmcc.2021.06.013","article-title":"FNDC5\/Irisin attenuates diabetic cardiomyopathy in a type 2 diabetes mouse model by activation of integrin alphaV\/beta5-AKT signaling and reduction of oxidative\/nitrosative stress","volume":"160","author":"Lin","year":"2021","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.metabol.2021.154910_bb0380","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1515\/intox-2017-0021","article-title":"Antioxidant SMe1EC2 modulates pentose phosphate pathway and glutathione-dependent enzyme activities in tissues of aged diabetic rats","volume":"10","author":"Ulusu","year":"2017","journal-title":"Interdiscip Toxicol"},{"key":"10.1016\/j.metabol.2021.154910_bb0385","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3389\/fendo.2019.00314","article-title":"Cardiovascular disease and diabetes","volume":"10","author":"Santulli","year":"2019","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.metabol.2021.154910_bb0390","doi-asserted-by":"crossref","first-page":"H409","DOI":"10.1152\/ajpheart.01332.2008","article-title":"Increased myocardial NAD(P)H oxidase-derived superoxide causes the exacerbation of postinfarct heart failure in type 2 diabetes","volume":"297","author":"Matsushima","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.metabol.2021.154910_bb0395","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.freeradbiomed.2012.07.010","article-title":"Oxidative and nitrosative stress in the maintenance of myocardial function","volume":"53","author":"Zhang","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.metabol.2021.154910_bb0400","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0021-9258(19)50785-2","article-title":"The function of cytidine coenzymes in the biosynthesis of phospholipides","volume":"222","author":"Kennedy","year":"1956","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2021.154910_bb0405","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1210\/er.2008-0007","article-title":"Glycerolipid metabolism and signaling in health and disease","volume":"29","author":"Prentki","year":"2008","journal-title":"Endocr Rev"},{"key":"10.1016\/j.metabol.2021.154910_bb0410","doi-asserted-by":"crossref","first-page":"13634","DOI":"10.1074\/jbc.M116.722496","article-title":"Type 2 Diabetes dysregulates glucose metabolism in cardiac progenitor cells","volume":"291","author":"Salabei","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2021.154910_bb0415","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41387-018-0045-x","article-title":"Update on glycerol-3-phosphate acyltransferases: the roles in the development of insulin resistance","volume":"8","author":"Yu","year":"2018","journal-title":"Nutr Diabetes"},{"key":"10.1016\/j.metabol.2021.154910_bb0420","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nm780","article-title":"A futile metabolic cycle activated in adipocytes by antidiabetic agents","volume":"8","author":"Guan","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2021.154910_bb0425","first-page":"H741","article-title":"Influence of metabolic substrate on rat heart function and metabolism at different coronary flows","volume":"261","author":"Burkhoff","year":"1991","journal-title":"Am J Phys"},{"key":"10.1016\/j.metabol.2021.154910_bb0430","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0022-2828(84)80718-X","article-title":"Inhibition of fatty acid oxidation and decrease of oxygen consumption of working rat heart by 4-bromocrotonic acid","volume":"16","author":"Hutter","year":"1984","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.metabol.2021.154910_bb0435","doi-asserted-by":"crossref","first-page":"H1345","DOI":"10.1152\/ajpheart.2000.278.4.H1345","article-title":"Myocardial substrate metabolism influences left ventricular energetics in vivo","volume":"278","author":"Korvald","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.metabol.2021.154910_bb0440","doi-asserted-by":"crossref","first-page":"H1631","DOI":"10.1152\/ajpheart.01190.2010","article-title":"Chronic and acute exposure of mouse hearts to fatty acids increases oxygen cost of excitation-contraction coupling","volume":"300","author":"Boardman","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.metabol.2021.154910_bb0445","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/0014-5793(91)80658-P","article-title":"Fatty acid circuit as a physiological mechanism of uncoupling of oxidative phosphorylation","volume":"294","author":"Skulachev","year":"1991","journal-title":"FEBS Lett"},{"key":"10.1016\/j.metabol.2021.154910_bb0450","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1096\/fj.03-0515fje","article-title":"Uncoupling protein 3 as a mitochondrial fatty acid anion exporter","volume":"17","author":"Schrauwen","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.metabol.2021.154910_bb0455","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3389\/fphys.2014.00282","article-title":"Mitochondrial and cellular mechanisms for managing lipid excess","volume":"5","author":"Aon","year":"2014","journal-title":"Front Physiol"},{"key":"10.1016\/j.metabol.2021.154910_bb0460","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1161\/01.CIR.0000072789.89096.10","article-title":"Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes","volume":"107","author":"Scheuermann-Freestone","year":"2003","journal-title":"Circulation."},{"key":"10.1016\/j.metabol.2021.154910_bb0465","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/j.bbadis.2016.07.020","article-title":"Acetylation control of cardiac fatty acid beta-oxidation and energy metabolism in obesity, diabetes, and heart failure","volume":"1862","author":"Fukushima","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.metabol.2021.154910_bb0470","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1126\/science.1179689","article-title":"Regulation of cellular metabolism by protein lysine acetylation","volume":"327","author":"Zhao","year":"2010","journal-title":"Science."},{"key":"10.1016\/j.metabol.2021.154910_bb0475","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.2337\/db19-0423","article-title":"Disturbed fatty acid oxidation, endoplasmic reticulum stress, and apoptosis in left ventricle of patients with type 2 Diabetes","volume":"68","author":"Ljubkovic","year":"2019","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2021.154910_bb0480","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1161\/CIRCRESAHA.120.317046","article-title":"NAD(+) repletion reverses heart failure with preserved ejection fraction","volume":"128","author":"Tong","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2021.154910_bb0485","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0022-2828(77)80367-2","article-title":"Association of glycogenolysis with cardiac sarcoplasmic reticulum: II. Effect of glycogen depletion, deoxycholate solubilization and cardiac ischemia: evidence for a phorphorylase kinase membrane complex","volume":"9","author":"Entman","year":"1977","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.metabol.2021.154910_bb0490","doi-asserted-by":"crossref","first-page":"H2400","DOI":"10.1152\/ajpheart.01030.2004","article-title":"Mechanistic model of cardiac energy metabolism predicts localization of glycolysis to cytosolic subdomain during ischemia","volume":"288","author":"Zhou","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.metabol.2021.154910_bb0495","doi-asserted-by":"crossref","first-page":"H1755","DOI":"10.1152\/ajpheart.00884.2006","article-title":"Increased expression of SERCA in the hearts of transgenic mice results in increased oxidation of glucose","volume":"292","author":"Belke","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.metabol.2021.154910_bb0500","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1161\/01.RES.77.1.88","article-title":"Functional coupling between glycolysis and sarcoplasmic reticulum Ca2+ transport","volume":"77","author":"Xu","year":"1995","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.metabol.2021.154910_bb0505","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3390\/jcm9020544","article-title":"Modulation of SERCA in patients with persistent atrial fibrillation treated by Epicardial Thoracoscopic ablation: the CAMAF study","volume":"9","author":"Sardu","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.metabol.2021.154910_bb0510","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1172\/JCI111718","article-title":"Functional compartmentation of glycolytic versus oxidative metabolism in isolated rabbit heart","volume":"75","author":"Weiss","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2021.154910_bb0515","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1161\/01.RES.70.6.1180","article-title":"Relation between glycolysis and calcium homeostasis in postischemic myocardium","volume":"70","author":"Jeremy","year":"1992","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2021.154910_bb0520","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2021.154910_bb0525","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1161\/CIRCRESAHA.109.206631","article-title":"Uncoupling protein-2 modulates myocardial excitation-contraction coupling","volume":"106","author":"Turner","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2021.154910_bb0530","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/CIRCRESAHA.120.318402","article-title":"CaMKII serine 280 O-GlcNAcylation links diabetic hyperglycemia to Proarrhythmia","volume":"129","author":"Hegyi","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2021.154910_bb0535","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00395-020-00820-0","article-title":"Intracellular O-linked glycosylation directly regulates cardiomyocyte L-type Ca(2+) channel activity and excitation-contraction coupling","volume":"115","author":"Ednie","year":"2020","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.metabol.2021.154910_bb0540","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","article-title":"Association between insulin resistance and the development of cardiovascular disease","volume":"17","author":"Ormazabal","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.metabol.2021.154910_bb0545","article-title":"Sodium-glucose cotransporter 2 inhibitors in heart failure","author":"Shah","year":"2021","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.metabol.2021.154910_bb0550","series-title":"\u201cEndocrinology of the heart in health and disease\u201d - doi: 10.1016\/B978-0-12-803111-7.00011-7","first-page":"285","article-title":"Adrenergic Receptors","author":"Ciccarelli","year":"2016"},{"key":"10.1016\/j.metabol.2021.154910_bb0555","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/0024-3205(79)90200-5","article-title":"Beta-adrenergic receptor decrease in diabetic rat hearts","volume":"25","author":"Savarese","year":"1979","journal-title":"Life Sci"},{"key":"10.1016\/j.metabol.2021.154910_bb0560","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/BF01908314","article-title":"Cardiac alpha- and beta-adrenergic receptor alterations in diabetic cardiomyopathy","volume":"77","author":"Heyliger","year":"1982","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.metabol.2021.154910_bb0565","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.2337\/diab.32.12.1110","article-title":"The adrenergic beta-receptor adenylate cyclase system in heart and lymphocytes from streptozotocin-diabetic rats. In vivo and in vitro evidence for a desensitized myocardial beta-receptor","volume":"32","author":"Gotzsche","year":"1983","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2021.154910_bb0570","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1476-5381.1991.tb12197.x","article-title":"Diabetes-induced changes in cardiac beta-adrenoceptor responsiveness: effects of aldose reductase inhibition with ponalrestat","volume":"102","author":"Austin","year":"1991","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.metabol.2021.154910_bb0575","doi-asserted-by":"crossref","first-page":"H1748","DOI":"10.1152\/ajpheart.00051.2016","article-title":"Deletion of thioredoxin-interacting protein improves cardiac inotropic reserve in the streptozotocin-induced diabetic heart","volume":"310","author":"Myers","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.metabol.2021.154910_bb0580","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3181\/00379727-193-42987","article-title":"The effects of estradiol and progesterone on reproductive tract atrophy and tissue adrenergic indices in diabetic C57BL\/KsJ mice","volume":"193","author":"Garris","year":"1990","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.metabol.2021.154910_bb0585","first-page":"E369","article-title":"Defective response to cAMP-dependent protein kinase in non-insulin-dependent diabetic heart","volume":"261","author":"Schaffer","year":"1991","journal-title":"Am J Phys"},{"key":"10.1016\/j.metabol.2021.154910_bb0590","first-page":"E636","article-title":"Heart rate control in diabetic rabbits: blunted response to isoproterenol","volume":"255","author":"Zola","year":"1988","journal-title":"Am J Phys"},{"key":"10.1016\/j.metabol.2021.154910_bb0595","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1139\/y04-101","article-title":"Altered inotropic reactivity in diabetic rabbit right ventricular myocardium","volume":"82","author":"Lee","year":"2004","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.metabol.2021.154910_bb0600","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/S0022-2828(95)91875-2","article-title":"Adrenergic desensitization in left ventricle from streptozotocin diabetic swine","volume":"27","author":"Roth","year":"1995","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.metabol.2021.154910_bb0605","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1139\/y00-133","article-title":"Diabetes reduces right atrial beta-adrenergic signaling but not agonist stimulation of heart rate in swine","volume":"79","author":"Stanley","year":"2001","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.metabol.2021.154910_bb0610","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2337\/diabetes.50.2.455","article-title":"The effect of diabetes on expression of beta1-, beta2-, and beta3-adrenoreceptors in rat hearts","volume":"50","author":"Dincer","year":"2001","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2021.154910_bb0615","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/01.anes.0000278909.40408.24","article-title":"Altered contractile response due to increased beta3-adrenoceptor stimulation in diabetic cardiomyopathy: the role of nitric oxide synthase 1-derived nitric oxide","volume":"107","author":"Amour","year":"2007","journal-title":"Anesthesiology."},{"issue":"105","key":"10.1016\/j.metabol.2021.154910_bb0620","first-page":"907","article-title":"Exercise training initiated after the onset of diabetes preserves myocardial function: effects on expression of beta-adrenoceptors","volume":"2008","author":"Bidasee","year":"1985","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.metabol.2021.154910_bb0625","doi-asserted-by":"crossref","DOI":"10.3390\/cells9122548","article-title":"Expression and signaling of beta-adrenoceptor subtypes in the diabetic heart","volume":"9","author":"Erdogan","year":"2020","journal-title":"Cells."},{"key":"10.1016\/j.metabol.2021.154910_bb0630","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11010-010-0611-6","article-title":"Effects of exercise training combined with insulin treatment on cardiac NOS1 signaling pathways in type 1 diabetic rats","volume":"347","author":"Le Douairon","year":"2011","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.metabol.2021.154910_bb0635","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejphar.2008.07.042","article-title":"Metoprolol increases the expression of beta(3)-adrenoceptors in the diabetic heart: effects on nitric oxide signaling and forkhead transcription factor-3","volume":"595","author":"Sharma","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.metabol.2021.154910_bb0640","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bbrc.2010.09.006","article-title":"Attenuation of beta2-adrenergic receptors and homocysteine metabolic enzymes cause diabetic cardiomyopathy","volume":"401","author":"Mishra","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2021.154910_bb0645","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012273","article-title":"Phosphodiesterase 5 associates with beta2 adrenergic receptor to modulate cardiac function in type 2 diabetic hearts","volume":"8","author":"West","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.metabol.2021.154910_bb0650","first-page":"H2334","article-title":"Depressed [Ca2+]i responses to isoproterenol and cAMP in isolated cardiomyocytes from experimental diabetic rats","volume":"266","author":"Yu","year":"1994","journal-title":"Am J Phys"},{"key":"10.1016\/j.metabol.2021.154910_bb0655","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071014","article-title":"Beta-blocker timolol prevents arrhythmogenic Ca(2)(+) release and normalizes Ca(2)(+) and Zn(2)(+) dyshomeostasis in hyperglycemic rat heart","volume":"8","author":"Tuncay","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2021.154910_bb0660","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/978-981-10-7757-9_11","article-title":"Ryanodine receptor structure and function in health and disease","volume":"87","author":"Santulli","year":"2018","journal-title":"Subcell Biochem"},{"issue":"106","key":"10.1016\/j.metabol.2021.154910_bb0665","first-page":"1280","article-title":"Exercise training during diabetes attenuates cardiac ryanodine receptor dysregulation","volume":"2009","author":"Shao","year":"1985","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.metabol.2021.154910_bb0670","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/CIRCULATIONAHA.116.022281","article-title":"Inhibiting insulin-mediated beta2-adrenergic receptor activation prevents Diabetes-associated cardiac dysfunction","volume":"135","author":"Wang","year":"2017","journal-title":"Circulation."},{"key":"10.1016\/j.metabol.2021.154910_bb0675","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s12265-015-9646-0","article-title":"Integrating GRK2 and NFkappaB in the pathophysiology of cardiac hypertrophy","volume":"8","author":"Sorriento","year":"2015","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.metabol.2021.154910_bb0680","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fphar.2019.00112","article-title":"G protein-coupled receptor kinase 2 (GRK2) as a potential therapeutic target in cardiovascular and metabolic diseases","volume":"10","author":"Murga","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.metabol.2021.154910_bb0685","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1478-811X-11-64","article-title":"GRK2 blockade with betaARKct is essential for cardiac beta2-adrenergic receptor signaling towards increased contractility","volume":"11","author":"Salazar","year":"2013","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.metabol.2021.154910_bb0690","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.amjcard.2010.12.006","article-title":"G protein-coupled receptor kinase 2 in patients with acute myocardial infarction","volume":"107","author":"Santulli","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.metabol.2021.154910_bb0695","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/cvr\/cvp252","article-title":"The G protein coupled receptor kinase 2 plays an essential role in beta-adrenergic receptor-induced insulin resistance","volume":"84","author":"Cipolletta","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.metabol.2021.154910_bb0700","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/1753-0407.12991","article-title":"G protein-coupled receptor kinase-2: a potential biomarker for early diabetic cardiomyopathy","volume":"12","author":"Lai","year":"2020","journal-title":"J Diabetes"},{"key":"10.1016\/j.metabol.2021.154910_bb0705","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061492","article-title":"Antidiabetic and Cardioprotective effects of pharmacological inhibition of GRK2 in db\/db mice","volume":"20","author":"Cipolletta","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2021.154910_bb0710","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1161\/CIRCRESAHA.116.309538","article-title":"Cardiac fibroblast GRK2 deletion enhances contractility and remodeling following ischemia\/reperfusion injury","volume":"119","author":"Woodall","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2021.154910_bb0715","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.2337\/diabetes.51.6.1938","article-title":"Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway","volume":"51","author":"Cai","year":"2002","journal-title":"Diabetes."},{"issue":"2","key":"10.1016\/j.metabol.2021.154910_bb0720","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/cvr\/cvn116","article-title":"Regulation of sarcolemmal glucose and fatty acid transporters in cardiac disease","volume":"79","author":"Schwenk","year":"2008","journal-title":"Cardiovasc Res"},{"issue":"13","key":"10.1016\/j.metabol.2021.154910_bb0725","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.3390\/ijms20133264","article-title":"Molecular dysfunction and phenotypic derangement in diabetic cardiomyopathy","volume":"20","author":"Evangelista","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2021.154910_bb0730","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/cvr\/cvy074","article-title":"Dietary fat is a key determinant in balancing mitochondrial dynamics in heart failure: a novel mechanism underlying the obesity paradox","volume":"114","author":"De Rosa","year":"2018","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.metabol.2021.154910_bb0735","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/cvr\/cvy052","article-title":"Enhancing fatty acid utilization ameliorates mitochondrial fragmentation and cardiac dysfunction via rebalancing optic atrophy 1 processing in the failing heart","volume":"114","author":"Guo","year":"2018","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.metabol.2021.154910_bb0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.166044","article-title":"Diabetic fibrosis","volume":"1867","author":"Tuleta","year":"2021","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"key":"10.1016\/j.metabol.2021.154910_bb0745","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.2337\/diacare.26.10.2949","article-title":"Diabetic cardiomyopathy","volume":"26","author":"Bell","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2021.154910_bb0750","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3389\/fendo.2019.00202","article-title":"Exenatide protects against cardiac dysfunction by attenuating oxidative stress in the diabetic mouse heart","volume":"10","author":"Ding","year":"2019","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.metabol.2021.154910_bb0755","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/453892","article-title":"Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis","volume":"2010","author":"Kaneto","year":"2010","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.metabol.2021.154910_bb0760","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.479258","article-title":"Cardioprotective effect of decorin in type 2 diabetes","volume":"11","author":"Chen","year":"2020","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.metabol.2021.154910_bb0765","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1161\/01.RES.86.12.1259","article-title":"Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro","volume":"86","author":"Siwik","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2021.154910_bb0770","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1210\/en.2007-0877","article-title":"Oxidative stress triggers cardiac fibrosis in the heart of diabetic rats","volume":"149","author":"Aragno","year":"2008","journal-title":"Endocrinology."},{"key":"10.1016\/j.metabol.2021.154910_bb0775","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2174\/1871529X11313020010","article-title":"Oxidative stress and transforming growth factor-beta1-induced cardiac fibrosis","volume":"13","author":"Purnomo","year":"2013","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"10.1016\/j.metabol.2021.154910_bb0780","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/CIRCRESAHA.110.217117","article-title":"Activation of protein kinase C isoforms and its impact on diabetic complications","volume":"106","author":"Geraldes","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2021.154910_bb0785","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21082896","article-title":"Diabetic cardiomyopathy and ischemic heart disease: prevention and therapy by exercise and conditioning","volume":"21","author":"Crisafulli","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2021.154910_bb0790","first-page":"165","article-title":"Oxidative stress and transforming growth factor-\u03b21-induced cardiac fibrosis","volume":"13","author":"Purnomo","year":"2013"},{"issue":"1","key":"10.1016\/j.metabol.2021.154910_bb0795","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3390\/ijms21010201","article-title":"Cardiosomal microRNAs are essential in post-infarction myofibroblast phenoconversion","volume":"21","author":"Morelli","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2021.154910_bb0800","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1161\/CIRCRESAHA.120.316958","article-title":"Myofibroblasts and fibrosis: mitochondrial and metabolic control of cellular differentiation","volume":"127","author":"Gibb","year":"2020","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.metabol.2021.154910_bb0805","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2337\/db06-1163","article-title":"Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy: the role of angiotensin type 1 receptor antagonism","volume":"56","author":"Westermann","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2021.154910_bb0810","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fphys.2018.00114","article-title":"Oxidative stress and NLRP3-Inflammasome activity as significant drivers of diabetic cardiovascular complications: therapeutic implications","volume":"9","author":"Sharma","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.metabol.2021.154910_bb0815","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/ni.1703","article-title":"The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis","volume":"10","author":"Franchi","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.metabol.2021.154910_bb0820","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3389\/fphys.2017.00519","article-title":"NLRP3 inflammasome as a molecular marker in diabetic cardiomyopathy","volume":"8","author":"Luo","year":"2017","journal-title":"Front Physiol"},{"key":"10.1016\/j.metabol.2021.154910_bb0825","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41421-020-0167-x","article-title":"Inflammasome activation and regulation: toward a better understanding of complex mechanisms","volume":"6","author":"Zheng","year":"2020","journal-title":"Cell Discov"},{"key":"10.1016\/j.metabol.2021.154910_bb0830","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.2337\/diabetes.51.4.1166","article-title":"Overexpression of the sarcoplasmic reticulum Ca2+ ATPase improves myocardial contractility in diabetic cardiomyopathy","volume":"51","author":"Trost","year":"2002","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2021.154910_bb0835","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10974-017-9470-z","article-title":"Physiology and pathophysiology of excitation-contraction coupling: the functional role of ryanodine receptor","volume":"38","author":"Santulli","year":"2017","journal-title":"J Muscle Res Cell Motil"},{"key":"10.1016\/j.metabol.2021.154910_bb0840","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/5584_2017_106","article-title":"New insights in cardiac calcium handling and excitation-contraction coupling","volume":"1067","author":"Gambardella","year":"2018","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"10.1016\/j.metabol.2021.154910_bb0845","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3390\/ijms20051197","article-title":"Molecular mechanisms responsible for diastolic dysfunction in diabetes mellitus patients","volume":"20","author":"Star\u010devi\u0107","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2021.154910_bb0850","first-page":"R1787","article-title":"Mechanisms of impaired calcium handling underlying subclinical diastolic dysfunction in diabetes","volume":"293","author":"Lacombe","year":"2007","journal-title":"Am J Phys Regul Integr Comp Phys"},{"key":"10.1016\/j.metabol.2021.154910_bb0855","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.7150\/thno.33684","article-title":"Targeting mitochondrial dynamics by regulating Mfn2 for therapeutic intervention in diabetic cardiomyopathy","volume":"9","author":"Hu","year":"2019","journal-title":"Theranostics."},{"key":"10.1016\/j.metabol.2021.154910_bb0860","doi-asserted-by":"crossref","first-page":"11389","DOI":"10.1073\/pnas.1513047112","article-title":"Mitochondrial calcium overload is a key determinant in heart failure","volume":"112","author":"Santulli","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.metabol.2021.154910_bb0865","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3390\/life11050436","article-title":"Mitochondrial bioenergetics and dynamism in the failing heart","volume":"11","author":"Morciano","year":"2021","journal-title":"Life"},{"key":"10.1016\/j.metabol.2021.154910_bb0870","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2019.09.006","article-title":"Emerging role of mitophagy in cardiovascular physiology and pathology","volume":"71","author":"Morales","year":"2020","journal-title":"Mol Asp Med"},{"key":"10.1016\/j.metabol.2021.154910_bb0875","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/s41401-020-0476-5","article-title":"Mitochondrial ca(2+) regulation in the etiology of heart failure: physiological and pathophysiological implications","volume":"41","author":"Xu","year":"2020","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.metabol.2021.154910_bb0880","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.atherosclerosis.2004.10.009","article-title":"Endothelium-ameliorating effects of statin therapy and coenzyme Q10 reductions in chronic heart failure","volume":"179","author":"Strey","year":"2005","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.metabol.2021.154910_bb0885","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/HYPERTENSIONAHA.116.07694","article-title":"Loss of Notch3 signaling in vascular smooth muscle cells promotes severe heart failure upon hypertension","volume":"68","author":"Ragot","year":"2016","journal-title":"Hypertension."},{"key":"10.1016\/j.metabol.2021.154910_bb0890","first-page":"219","article-title":"Albuminuria reflects widespread vascular damage","volume":"32","author":"Deckert","year":"1989","journal-title":"Steno Hypothesis Diabetol"},{"key":"10.1016\/j.metabol.2021.154910_bb0895","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1742-1241.2007.01620.x","article-title":"Microalbuminuria screening in patients with hypertension: recommendations for clinical practice","volume":"62","author":"Volpe","year":"2008","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.metabol.2021.154910_bb0900","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s001250051151","article-title":"Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas","volume":"42","author":"Mogensen","year":"1999","journal-title":"Diabetologia."},{"key":"10.1016\/j.metabol.2021.154910_bb0905","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1161\/CIRCRESAHA.116.306923","article-title":"Molecular and cellular mechanisms of cardiovascular disorders in diabetes","volume":"118","author":"Shah","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2021.154910_bb0910","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.2337\/db07-0019","article-title":"Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy","volume":"56","author":"Toyoda","year":"2007","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2021.154910_bb0915","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/bjo.59.11.649","article-title":"Early breakdown of the blood-retinal barrier in diabetes","volume":"59","author":"Cunha-Vaz","year":"1975","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.metabol.2021.154910_bb0920","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF00428983","article-title":"The effect of metabolic regulation on microvascular permeability to small and large molecules in short-term juvenile diabetics","volume":"12","author":"Parving","year":"1976","journal-title":"Diabetologia."},{"key":"10.1016\/j.metabol.2021.154910_bb0925","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1007\/s001250050619","article-title":"Macro-microangiopathy and endothelial dysfunction in NIDDM patients with and without diabetic nephropathy","volume":"39","author":"Parving","year":"1996","journal-title":"Diabetologia."},{"key":"10.1016\/j.metabol.2021.154910_bb0930","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJM198211183072103","article-title":"Patterns of diffusion through skin capillaries in patients with long-term diabetes","volume":"307","author":"Bollinger","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2021.154910_bb0935","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/labinvest.3780139","article-title":"Interaction of endothelin-1 with vasoactive factors in mediating glucose-induced increased permeability in endothelial cells","volume":"80","author":"Chen","year":"2000","journal-title":"Lab Investig"},{"key":"10.1016\/j.metabol.2021.154910_bb0940","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.2337\/diacare.25.12.2328","article-title":"Macular edema reflects generalized vascular hyperpermeability in type 2 diabetic patients with retinopathy","volume":"25","author":"Knudsen","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2021.154910_bb0945","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12013-007-0041-6","article-title":"A role for the endothelial glycocalyx in regulating microvascular permeability in diabetes mellitus","volume":"49","author":"Perrin","year":"2007","journal-title":"Cell Biochem Biophys"},{"key":"10.1016\/j.metabol.2021.154910_bb0950","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1097\/00004872-199917121-00021","article-title":"Transcapillary escape rate of albumin is increased and related to haemodynamic changes in normo-albuminuric type 1 diabetic patients","volume":"17","author":"Vervoort","year":"1999","journal-title":"J Hypertens"},{"key":"10.1016\/j.metabol.2021.154910_bb0955","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2337\/diab.36.7.813","article-title":"Increased vascular permeability in spontaneously diabetic BB\/W rats and in rats with mild versus severe streptozocin-induced diabetes. Prevention by aldose reductase inhibitors and castration","volume":"36","author":"Williamson","year":"1987","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2021.154910_bb0960","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/01.RES.87.5.412","article-title":"Protein kinase C activation contributes to microvascular barrier dysfunction in the heart at early stages of diabetes","volume":"87","author":"Yuan","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2021.154910_bb0965","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1083\/jcb.140.4.947","article-title":"Vascular endothelial growth factor induces endothelial fenestrations in vitro","volume":"140","author":"Esser","year":"1998","journal-title":"J Cell Biol"},{"key":"10.1016\/j.metabol.2021.154910_bb0970","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/jdi.12255","article-title":"Cell biology of diabetic nephropathy: roles of endothelial cells, tubulointerstitial cells and podocytes","volume":"6","author":"Maezawa","year":"2015","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.metabol.2021.154910_bb0975","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1681\/ASN.2015020208","article-title":"Cathepsin S cleavage of protease-activated Receptor-2 on endothelial cells promotes microvascular Diabetes complications","volume":"27","author":"Kumar Vr","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.metabol.2021.154910_bb0980","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1111\/j.1538-7836.2005.01610.x","article-title":"Protease-activated receptors-1 and -2 can mediate endothelial barrier protection: role in factor Xa signaling","volume":"3","author":"Feistritzer","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.metabol.2021.154910_bb0985","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1111\/j.1476-5381.1995.tb15132.x","article-title":"Impaired endothelium-dependent relaxation in isolated resistance arteries of spontaneously diabetic rats","volume":"116","author":"Heygate","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.metabol.2021.154910_bb0990","doi-asserted-by":"crossref","first-page":"F480","DOI":"10.1152\/ajprenal.2001.280.3.F480","article-title":"Glucose scavenging of nitric oxide","volume":"280","author":"Brodsky","year":"2001","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.metabol.2021.154910_bb0995","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1161\/01.HYP.37.2.744","article-title":"Workshop: endothelial cell dysfunction leading to diabetic nephropathy\u202f: focus on nitric oxide","volume":"37","author":"Goligorsky","year":"2001","journal-title":"Hypertension."},{"key":"10.1016\/j.metabol.2021.154910_bb1000","doi-asserted-by":"crossref","first-page":"H2130","DOI":"10.1152\/ajpheart.00196.2002","article-title":"Hyperglycemic switch from mitochondrial nitric oxide to superoxide production in endothelial cells","volume":"283","author":"Brodsky","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.metabol.2021.154910_bb1005","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.2337\/db09-1772","article-title":"Nitric oxide synthesis is reduced in subjects with type 2 diabetes and nephropathy","volume":"59","author":"Tessari","year":"2010","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2021.154910_bb1010","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","article-title":"Oxidative stress and diabetic complications","volume":"107","author":"Giacco","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2021.154910_bb1015","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1097\/01.ASN.0000135971.88164.2C","article-title":"Nephropathy in Zucker diabetic fat rat is associated with oxidative and nitrosative stress: prevention by chronic therapy with a peroxynitrite scavenger ebselen","volume":"15","author":"Chander","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.metabol.2021.154910_bb1020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/10623320490482619","article-title":"Peroxynitrite and vascular endothelial dysfunction in diabetes mellitus","volume":"11","author":"Zou","year":"2004","journal-title":"Endothelium."},{"key":"10.1016\/j.metabol.2021.154910_bb1025","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.prostaglandins.2006.05.005","article-title":"Peroxynitrite and protein tyrosine nitration of prostacyclin synthase","volume":"82","author":"Zou","year":"2007","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.metabol.2021.154910_bb1030","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s11892-013-0453-1","article-title":"Advanced glycation end products (AGE) and diabetes: cause, effect, or both?","volume":"14","author":"Vlassara","year":"2014","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.metabol.2021.154910_bb1035","doi-asserted-by":"crossref","first-page":"F266","DOI":"10.1152\/ajprenal.00473.2016","article-title":"Vascular endothelium in diabetes","volume":"312","author":"Goligorsky","year":"2017","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.metabol.2021.154910_bb1040","doi-asserted-by":"crossref","first-page":"36088","DOI":"10.1074\/jbc.M801698200","article-title":"In skeletal muscle advanced glycation end products (AGEs) inhibit insulin action and induce the formation of multimolecular complexes including the receptor for AGEs","volume":"283","author":"Cassese","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2021.154910_bb1045","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.636267","article-title":"Aldose reductase: an emerging target for development of interventions for diabetic cardiovascular complications","volume":"12","author":"Jannapureddy","year":"2021","journal-title":"Front Endocrinol"},{"issue":"3","key":"10.1016\/j.metabol.2021.154910_bb1050","doi-asserted-by":"crossref","first-page":"970","DOI":"10.3390\/ijms21030970","article-title":"The diabetic cardiac fibroblast: mechanisms underlying phenotype and function","volume":"21","author":"Levick","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.metabol.2021.154910_bb1055","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2021.154910_bb1060","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.cellsig.2009.02.014","article-title":"SIRT1: regulation of longevity via autophagy","volume":"21","author":"Salminen","year":"2009","journal-title":"Cell Signal"},{"key":"10.1016\/j.metabol.2021.154910_bb1065","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tips.2013.12.004","article-title":"Small molecule SIRT1 activators for the treatment of aging and age-related diseases","volume":"35","author":"Hubbard","year":"2014","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.metabol.2021.154910_bb1070","doi-asserted-by":"crossref","first-page":"521","DOI":"10.4161\/auto.5904","article-title":"Autophagy: the missing link between non-enzymatically glycated proteins inducing apoptosis and premature senescence of endothelial cells?","volume":"4","author":"Patschan","year":"2008","journal-title":"Autophagy."},{"key":"10.1016\/j.metabol.2021.154910_bb1075","doi-asserted-by":"crossref","first-page":"F100","DOI":"10.1152\/ajprenal.00261.2007","article-title":"Mapping mechanisms and charting the time course of premature cell senescence and apoptosis: lysosomal dysfunction and ganglioside accumulation in endothelial cells","volume":"294","author":"Patschan","year":"2008","journal-title":"Am J Physiol Ren Physiol"},{"issue":"3","key":"10.1016\/j.metabol.2021.154910_bb1080","doi-asserted-by":"crossref","first-page":"H1119","DOI":"10.1152\/ajpheart.00713.2007","article-title":"Lipid mediators of autophagy in stress-induced premature senescence of endothelial cells","volume":"294","author":"Patschan","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.metabol.2021.154910_bb1085","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.ajpath.2011.11.033","article-title":"Cathepsin cleavage of sirtuin 1 in endothelial progenitor cells mediates stress-induced premature senescence","volume":"180","author":"Chen","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.metabol.2021.154910_bb1090","series-title":"Physiology C Regulation of ACE2 in cardiac myocytes and fibroblasts","volume":"295","author":"Gallagher","year":"2008"},{"key":"10.1016\/j.metabol.2021.154910_bb1095","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1210\/en.2015-1709","article-title":"Deletion of IGF-1 receptors in cardiomyocytes attenuates cardiac aging in male mice","volume":"157","author":"Ock","year":"2016","journal-title":"Endocrinology."},{"key":"10.1016\/j.metabol.2021.154910_bb1100","first-page":"V65","article-title":"The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64\u202fyears old: 30\u202fyears of follow-up in the Framingham study","volume":"75","author":"Stokes","year":"1987","journal-title":"Circulation."},{"key":"10.1016\/j.metabol.2021.154910_bb1105","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2021.154910_bb1110","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1056\/NEJM198412203112506","article-title":"Current concepts. vascular and microvascular disease of the foot in diabetes. Implications for foot care","volume":"311","author":"LoGerfo","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2021.154910_bb1115","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.atherosclerosis.2021.03.034","article-title":"Targeting the phenotypic switch of vascular smooth muscle cells to tackle atherosclerosis","volume":"324","author":"Kansakar","year":"2021","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.metabol.2021.154910_bb1120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20225694","article-title":"The role of vascular smooth muscle cells in arterial remodeling: focus on calcification-related processes","volume":"20","author":"Jaminon","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2021.154910_bb1125","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1067\/mva.2001.111806","article-title":"Human vascular smooth muscle cells of diabetic origin exhibit increased proliferation, adhesion, and migration","volume":"33","author":"Faries","year":"2001","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.metabol.2021.154910_bb1130","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.2337\/dc12-1507","article-title":"Impact of diabetes on long-term outcome after primary angioplasty: insights from the DESERT cooperation","volume":"36","author":"De Luca","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2021.154910_bb1135","doi-asserted-by":"crossref","DOI":"10.2337\/dc21-0939","article-title":"Hyperglycemia drives stent restenosis in STEMI patients","author":"Mone","year":"2021","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.metabol.2021.154910_bb1140","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s12013-013-9672-y","article-title":"Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction: junctin as a target protein of miR-1","volume":"67","author":"Yildirim","year":"2013","journal-title":"Cell Biochem Biophys"},{"key":"10.1016\/j.metabol.2021.154910_bb1145","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1161\/ATVBAHA.115.306770","article-title":"Regulation of vascular smooth muscle cell dysfunction under diabetic conditions by miR-504","volume":"36","author":"Reddy","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2021.154910_bb1150","first-page":"2012","article-title":"miR132 inhibits high glucoseinduced vascular smooth muscle cell proliferation and migration by targeting E2F5","volume":"20","author":"Xu","year":"2019","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.metabol.2021.154910_bb1155","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.gene.2016.04.027","article-title":"MicroRNA-24 inhibits high glucose-induced vascular smooth muscle cell proliferation and migration by targeting HMGB1","volume":"586","author":"Yang","year":"2016","journal-title":"Gene."},{"key":"10.1016\/j.metabol.2021.154910_bb1160","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1146\/annurev-physiol-012110-142315","article-title":"Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease","volume":"74","author":"Alexander","year":"2012","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.metabol.2021.154910_bb1165","first-page":"C1175","article-title":"Kruppel-like factor 4, Elk-1, and histone deacetylases cooperatively suppress smooth muscle cell differentiation markers in response to oxidized phospholipids","volume":"295","author":"Yoshida","year":"2008","journal-title":"Am J Phys Cell Phys"},{"key":"10.1016\/j.metabol.2021.154910_bb1170","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1161\/CIRCRESAHA.108.176974","article-title":"Conditional deletion of Kruppel-like factor 4 delays downregulation of smooth muscle cell differentiation markers but accelerates neointimal formation following vascular injury","volume":"102","author":"Yoshida","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2021.154910_bb1175","doi-asserted-by":"crossref","first-page":"7195","DOI":"10.1002\/jcp.26549","article-title":"MicroRNA-dependent regulation of KLF4 by glucose in vascular smooth muscle","volume":"233","author":"Hien","year":"2018","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.metabol.2021.154910_bb1180","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ceca.2014.08.007","article-title":"Ca(2+) handling alterations and vascular dysfunction in diabetes","volume":"56","author":"Fernandez-Velasco","year":"2014","journal-title":"Cell Calcium"},{"key":"10.1016\/j.metabol.2021.154910_bb1185","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1475-2840-9-8","article-title":"Intracellular Ca2+ regulating proteins in vascular smooth muscle cells are altered with type 1 diabetes due to the direct effects of hyperglycemia","volume":"9","author":"Searls","year":"2010","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.metabol.2021.154910_bb1190","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1126\/science.270.5236.633","article-title":"Relaxation of arterial smooth muscle by calcium sparks","volume":"270","author":"Nelson","year":"1995","journal-title":"Science."},{"key":"10.1016\/j.metabol.2021.154910_bb1195","article-title":"Role of ryanodine receptor subtypes in initiation and formation of calcium sparks in arterial smooth muscle: comparison with striated muscle","volume":"2009","author":"Essin","year":"2009","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.metabol.2021.154910_bb1200","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1440-1681.2007.04832.x","article-title":"Abnormalities of sarcoplasmic reticulum Ca2+ mobilization in aortic smooth muscle cells from streptozotocin-induced diabetic rats","volume":"35","author":"Ma","year":"2008","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.metabol.2021.154910_bb1205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053321","article-title":"Abnormal Ca2+ spark\/STOC coupling in cerebral artery smooth muscle cells of obese type 2 diabetic mice","volume":"8","author":"Rueda","year":"2013","journal-title":"PLoS One"},{"issue":"Suppl. 3","key":"10.1016\/j.metabol.2021.154910_bb1210","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.1007\/s11739-012-0804-y","article-title":"Diabetes and sex: from pathophysiology to personalized medicine","volume":"7","author":"Abbate","year":"2012","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.metabol.2021.154910_bb1215","doi-asserted-by":"crossref","first-page":"12565","DOI":"10.1073\/pnas.0702489104","article-title":"Apoptosis regulation by Bcl-x(L) modulation of mammalian inositol 1,4,5-trisphosphate receptor channel isoform gating","volume":"104","author":"Li","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2021.154910_bb1220","doi-asserted-by":"crossref","first-page":"H124","DOI":"10.1152\/ajpheart.00218.2011","article-title":"Calcium homeostasis in vascular smooth muscle cells is altered in type 2 diabetes by Bcl-2 protein modulation of InsP3R calcium release channels","volume":"302","author":"Velmurugan","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.metabol.2021.154910_bb1225","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/ncb1302","article-title":"The endoplasmic reticulum gateway to apoptosis by Bcl-X(L) modulation of the InsP3R","volume":"7","author":"White","year":"2005","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.metabol.2021.154910_bb1230","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.2337\/db05-0949","article-title":"Human vascular smooth muscle cells from diabetic patients are resistant to induced apoptosis due to high Bcl-2 expression","volume":"55","author":"Ruiz","year":"2006","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2021.154910_bb1235","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1161\/01.RES.87.7.574","article-title":"Hyperglycemia inhibits vascular smooth muscle cell apoptosis through a protein kinase C-dependent pathway","volume":"87","author":"Hall","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2021.154910_bb1240","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1262-3636(07)70166-0","article-title":"Fas\/Fas-ligand pathway is impaired in patients with type 2 diabetes. Influence of hypertension and insulin resistance","volume":"31","author":"Cosson","year":"2005","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.metabol.2021.154910_bb1245","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/01.STR.0000115752.58601.0B","article-title":"Carotid arterial remodeling: a maladaptive phenomenon in type 2 diabetes but not in impaired glucose metabolism: the Hoorn study","volume":"35","author":"Henry","year":"2004","journal-title":"Stroke."},{"key":"10.1016\/j.metabol.2021.154910_bb1250","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1172\/JCI118604","article-title":"Increased atherosclerosis in streptozotocin-induced diabetic mice","volume":"97","author":"Kunjathoor","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2021.154910_bb1255","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2337\/diabetes.47.6.859","article-title":"Protein kinase C activation and the development of diabetic complications","volume":"47","author":"Koya","year":"1998","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2021.154910_bb1260","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.2337\/diabetes.52.10.2562","article-title":"Insulin affects vascular smooth muscle cell phenotype and migration via distinct signaling pathways","volume":"52","author":"Wang","year":"2003","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2021.154910_bb1265","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/401723","article-title":"Spontaneous type 2 diabetic rodent models","volume":"2013","author":"Wang","year":"2013","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.metabol.2021.154910_bb1270","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-1-62703-068-7_10","article-title":"Experimentally induced rodent models of type 2 diabetes","volume":"933","author":"Islam","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.metabol.2021.154910_bb1275","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/jdi.12235","article-title":"Modeling type 2 diabetes in rats using high fat diet and streptozotocin","volume":"5","author":"Skovso","year":"2014","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.metabol.2021.154910_bb1280","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1475-2840-12-136","article-title":"Cardiac metabolism in a new rat model of type 2 diabetes using high-fat diet with low dose streptozotocin","volume":"12","author":"Mansor","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.metabol.2021.154910_bb1285","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/abr.abr_8_17","article-title":"Novel high-fat diet formulation and Streptozotocin treatment for induction of prediabetes and type 2 Diabetes in rats","volume":"7","author":"Vatandoust","year":"2018","journal-title":"Adv Biomed Res"},{"key":"10.1016\/j.metabol.2021.154910_bb1290","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1631\/jzus.B1700254","article-title":"Stability of a type 2 diabetes rat model induced by high-fat diet feeding with low-dose streptozotocin injection","volume":"19","author":"Guo","year":"2018","journal-title":"J Zhejiang Univ Sci B"},{"key":"10.1016\/j.metabol.2021.154910_bb1295","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.phrs.2005.05.004","article-title":"Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening","volume":"52","author":"Srinivasan","year":"2005","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.metabol.2021.154910_bb1300","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.2337\/diabetes.54.6.1846","article-title":"Reduction of hepatic and adipose tissue glucocorticoid receptor expression with antisense oligonucleotides improves hyperglycemia and hyperlipidemia in diabetic rodents without causing systemic glucocorticoid antagonism","volume":"54","author":"Watts","year":"2005","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2021.154910_bb1305","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.metabol.2007.04.021","article-title":"Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: the fat-fed, streptozotocin-treated rat","volume":"56","author":"Sahin","year":"2007","journal-title":"Metabolism."},{"key":"10.1016\/j.metabol.2021.154910_bb1310","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1053\/meta.2000.17721","article-title":"A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat","volume":"49","author":"Reed","year":"2000","journal-title":"Metabolism."},{"key":"10.1016\/j.metabol.2021.154910_bb1315","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jep.2013.11.015","article-title":"The anti-inflammation effect of Moutan cortex on advanced glycation end products-induced rat mesangial cells dysfunction and high-glucose-fat diet and streptozotocin-induced diabetic nephropathy rats","volume":"151","author":"Zhang","year":"2014","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.metabol.2021.154910_bb1320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162131","article-title":"Mouse models of diabetes, obesity and related kidney disease","volume":"11","author":"Glastras","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2021.154910_bb1325","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/oby.2007.582","article-title":"Enhanced muscle mixed and mitochondrial protein synthesis rates after a high-fat or high-sucrose diet","volume":"15","author":"Chanseaume","year":"2007","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.metabol.2021.154910_bb1330","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.3389\/fphys.2018.01054","article-title":"High fat with high sucrose diet leads to obesity and induces Myodegeneration","volume":"9","author":"Rasool","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.metabol.2021.154910_bb1335","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.00334.2015","article-title":"Long-term oral administration of osteocalcin induces insulin resistance in male mice fed a high-fat, high-sucrose diet","volume":"310","author":"Yasutake","year":"2016","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2021.154910_bb1340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113459","article-title":"A novel mouse model of advanced diabetic kidney disease","volume":"9","author":"Thibodeau","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2021.154910_bb1345","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ar.20625","article-title":"Podocyte loss in aging OVE26 diabetic mice","volume":"291","author":"Teiken","year":"2008","journal-title":"Anat Rec"},{"key":"10.1016\/j.metabol.2021.154910_bb1350","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.2337\/diabetes.53.12.3248","article-title":"Development of late-stage diabetic nephropathy in OVE26 diabetic mice","volume":"53","author":"Zheng","year":"2004","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2021.154910_bb1355","doi-asserted-by":"crossref","first-page":"12435","DOI":"10.1074\/jbc.M114.562587","article-title":"Inhibition of pancreatic beta-cell Ca2+\/calmodulin-dependent protein kinase II reduces glucose-stimulated calcium influx and insulin secretion, impairing glucose tolerance","volume":"289","author":"Dadi","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2021.154910_bb1360","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/0092-8674(89)90505-9","article-title":"Calmodulin-induced early-onset diabetes in transgenic mice","volume":"58","author":"Epstein","year":"1989","journal-title":"Cell."},{"key":"10.1016\/j.metabol.2021.154910_bb1365","first-page":"1387","article-title":"Elevated beta-cell calmodulin produces a unique insulin secretory defect in transgenic mice","volume":"130","author":"Epstein","year":"1992","journal-title":"Endocrinology."},{"key":"10.1016\/j.metabol.2021.154910_bb1370","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1900\/RDS.2007.4.159","article-title":"Diabetic cardiomyopathy in OVE26 mice shows mitochondrial ROS production and divergence between in vivo and in vitro contractility","volume":"4","author":"Song","year":"2007","journal-title":"Rev Diabet Stud"},{"key":"10.1016\/j.metabol.2021.154910_bb1375","doi-asserted-by":"crossref","first-page":"6961348","DOI":"10.1155\/2020\/6961348","article-title":"Sex differences in progression of diabetic cardiomyopathy in OVE26 type 1 diabetic mice","volume":"2020","author":"Tang","year":"2020","journal-title":"Oxidative Med Cell Longev"},{"key":"10.1016\/j.metabol.2021.154910_bb1380","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2174\/1573399810666140508121012","article-title":"Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes","volume":"10","author":"Wang","year":"2014","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.metabol.2021.154910_bb1385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189784","article-title":"Energy homeostasis in leptin deficient Lepob\/Ob mice","volume":"12","author":"Skowronski","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2021.154910_bb1390","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1101\/gr.5.1.5","article-title":"The human obese (OB) gene: RNA expression pattern and mapping on the physical, cytogenetic, and genetic maps of chromosome 7","volume":"5","author":"Green","year":"1995","journal-title":"Genome Res"},{"key":"10.1016\/j.metabol.2021.154910_bb1395","doi-asserted-by":"crossref","first-page":"31937","DOI":"10.1074\/jbc.272.51.31937","article-title":"The molecular genetics of rodent single gene obesities","volume":"272","author":"Leibel","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2021.154910_bb1400","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1021\/cr0204653","article-title":"Chemistry and biochemistry of type 2 diabetes","volume":"104","author":"Ross","year":"2004","journal-title":"Chem Rev"},{"key":"10.1016\/j.metabol.2021.154910_bb1405","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF00429772","article-title":"Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice","volume":"14","author":"Coleman","year":"1978","journal-title":"Diabetologia."},{"key":"10.1016\/j.metabol.2021.154910_bb1410","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2020.01.018","article-title":"Lipid accumulation in hearts transplanted From nondiabetic donors to diabetic recipients","volume":"75","author":"Marfella","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2021.154910_bb1415","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1475-2840-6-14","article-title":"Noninvasive and invasive evaluation of cardiac dysfunction in experimental diabetes in rodents","volume":"6","author":"Wichi","year":"2007","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.metabol.2021.154910_bb1420","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1210\/en.2005-0938","article-title":"Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity","volume":"146","author":"Buchanan","year":"2005","journal-title":"Endocrinology."},{"key":"10.1016\/j.metabol.2021.154910_bb1425","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.2337\/db14-1050","article-title":"Lowering body weight in obese mice with diastolic heart failure improves cardiac insulin sensitivity and function: implications for the obesity paradox","volume":"64","author":"Sankaralingam","year":"2015","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2021.154910_bb1430","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.2337\/diabetes.53.9.2366","article-title":"Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant Ob\/Ob mouse hearts","volume":"53","author":"Mazumder","year":"2004","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2021.154910_bb1435","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1021\/acs.jproteome.5b00128","article-title":"Comprehensive metabolic profiling of age-related mitochondrial dysfunction in the high-fat-fed Ob\/Ob mouse heart","volume":"14","author":"Wang","year":"2015","journal-title":"J Proteome Res"},{"key":"10.1016\/j.metabol.2021.154910_bb1440","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1002\/art.24854","article-title":"Extreme obesity due to impaired leptin signaling in mice does not cause knee osteoarthritis","volume":"60","author":"Griffin","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.metabol.2021.154910_bb1445","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0026-0495(94)90194-5","article-title":"Characterization of plasma lipids in genetically obese mice: the mutants obese, diabetes, fat, tubby, and lethal yellow","volume":"43","author":"Nishina","year":"1994","journal-title":"Metabolism."},{"key":"10.1016\/j.metabol.2021.154910_bb1450","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0026-0495(00)90588-2","article-title":"The db\/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of Western diet feeding","volume":"49","author":"Kobayashi","year":"2000","journal-title":"Metabolism."},{"key":"10.1016\/j.metabol.2021.154910_bb1455","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-1-62703-068-7_4","article-title":"Diabetes in mice with monogenic obesity: the db\/db mouse and its use in the study of cardiac consequences","volume":"933","author":"Belke","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.metabol.2021.154910_bb1460","doi-asserted-by":"crossref","first-page":"H976","DOI":"10.1152\/ajpheart.00088.2002","article-title":"Echocardiographic assessment of cardiac function in diabetic db\/db and transgenic db\/db-hGLUT4 mice","volume":"283","author":"Semeniuk","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.metabol.2021.154910_bb1465","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00238.2018","article-title":"Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction","volume":"315","author":"Alex","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.metabol.2021.154910_bb1470","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00395-018-0711-0","article-title":"Of mice and men: models and mechanisms of diabetic cardiomyopathy","volume":"114","author":"Riehle","year":"2018","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.metabol.2021.154910_bb1475","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1089\/ars.2009.2531","article-title":"Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities","volume":"12","author":"Sivitz","year":"2010","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.metabol.2021.154910_bb1480","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1006\/bbrc.1996.1070","article-title":"Substitution at codon 269 (glutamine --> proline) of the leptin receptor (OB-R) cDNA is the only mutation found in the Zucker fatty (fa\/fa) rat","volume":"224","author":"Iida","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2021.154910_bb1485","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ng0596-18","article-title":"Leptin receptor missense mutation in the fatty Zucker rat","volume":"13","author":"Phillips","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.metabol.2021.154910_bb1490","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/bs.irn.2016.03.002","article-title":"Alternatives to the Streptozotocin-diabetic rodent","volume":"127","author":"Yorek","year":"2016","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.metabol.2021.154910_bb1495","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/103731","article-title":"A novel rat model of type 2 Diabetes: the Zucker fatty Diabetes mellitus ZFDM rat","volume":"2013","author":"Yokoi","year":"2013","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.metabol.2021.154910_bb1500","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3181\/00379727-173-41611","article-title":"The diabetic Zucker fatty rat","volume":"173","author":"Clark","year":"1983","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.metabol.2021.154910_bb1505","doi-asserted-by":"crossref","first-page":"H2102","DOI":"10.1152\/ajpheart.00935.2004","article-title":"Impact of altered substrate utilization on cardiac function in isolated hearts from Zucker diabetic fatty rats","volume":"288","author":"Wang","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.metabol.2021.154910_bb1510","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1242\/dmm.001941","article-title":"Rodent models of diabetic cardiomyopathy","volume":"2","author":"Bugger","year":"2009","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.metabol.2021.154910_bb1515","doi-asserted-by":"crossref","first-page":"E113","DOI":"10.1152\/ajpendo.00594.2004","article-title":"Progression of vascular and neural dysfunction in sciatic nerves of Zucker diabetic fatty and Zucker rats","volume":"289","author":"Oltman","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2021.154910_bb1520","doi-asserted-by":"crossref","first-page":"40567","DOI":"10.1074\/jbc.M100052200","article-title":"Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats","volume":"276","author":"Luiken","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2021.154910_bb1525","first-page":"R793","article-title":"High levels of myocardial antioxidant defense in aging nondiabetic normotensive Zucker obese rats","volume":"286","author":"Conti","year":"2004","journal-title":"Am J Phys Regul Integr Comp Phys"},{"key":"10.1016\/j.metabol.2021.154910_bb1530","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/sj.ijo.0801536","article-title":"Mechanism for obesity-induced increase in myocardial lipid peroxidation","volume":"25","author":"Vincent","year":"2001","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.metabol.2021.154910_bb1535","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.2337\/diabetes.51.8.2587","article-title":"Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart","volume":"51","author":"Young","year":"2002","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2021.154910_bb1540","doi-asserted-by":"crossref","first-page":"E704","DOI":"10.1152\/ajpendo.2001.281.4.E704","article-title":"Electrostimulation enhances FAT\/CD36-mediated long-chain fatty acid uptake by isolated rat cardiac myocytes","volume":"281","author":"Luiken","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2021.154910_bb1545","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2337\/diabetes.47.3.358","article-title":"Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat","volume":"47","author":"Pick","year":"1998","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2021.154910_bb1550","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1475-2840-9-25","article-title":"Diabetic cardiomyopathy in Zucker diabetic fatty rats: the forgotten right ventricle","volume":"9","author":"van den Brom","year":"2010","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.metabol.2021.154910_bb1555","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1073\/pnas.97.4.1784","article-title":"Lipotoxic heart disease in obese rats: implications for human obesity","volume":"97","author":"Zhou","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2021.154910_bb1560","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1096\/fj.04-2263com","article-title":"Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart","volume":"18","author":"Sharma","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.metabol.2021.154910_bb1565","doi-asserted-by":"crossref","first-page":"E328","DOI":"10.1152\/ajpendo.00055.2005","article-title":"Activation of PPARgamma enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF rats","volume":"289","author":"Golfman","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2021.154910_bb1570","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0008-6363(02)00399-1","article-title":"Cardiac carbohydrate metabolism in Zucker diabetic fatty rats","volume":"55","author":"Chatham","year":"2002","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.metabol.2021.154910_bb1575","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0140-6736(54)90924-1","article-title":"Diabetic angiopathy: a specific vascular disease","volume":"266","author":"Lundbaek","year":"1954","journal-title":"Lancet."},{"key":"10.1016\/j.metabol.2021.154910_bb1580","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","article-title":"New type of cardiomyopathy associated with diabetic glomerulosclerosis","volume":"30","author":"Rubler","year":"1972","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.metabol.2021.154910_bb1585","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2337\/diacare.24.1.5","article-title":"Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes. Importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy","volume":"24","author":"Poirier","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2021.154910_bb1590","doi-asserted-by":"crossref","DOI":"10.1177\/2042018819834869","article-title":"Diabetic cardiomyopathy: prevalence, determinants and potential treatments","volume":"10","author":"Gulsin","year":"2019","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.metabol.2021.154910_bb1595","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/jch.13453","article-title":"Diabetes, body fat, skeletal muscle, and hypertension: the ominous chiasmus?","volume":"21","author":"Shu","year":"2019","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.metabol.2021.154910_bb1600","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fendo.2017.00160","article-title":"Targeting obesity and Diabetes to treat heart failure with preserved ejection fraction","volume":"8","author":"Altara","year":"2017","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.metabol.2021.154910_bb1605","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1210\/er.2003-0012","article-title":"Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications","volume":"25","author":"Fang","year":"2004","journal-title":"Endocr Rev"},{"key":"10.1016\/j.metabol.2021.154910_bb1610","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00059-011-3429-4","article-title":"Diabetic cardiomyopathy--fact or fiction?","volume":"36","author":"Maisch","year":"2011","journal-title":"Herz."},{"key":"10.1016\/j.metabol.2021.154910_bb1615","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy","volume":"122","author":"Jia","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2021.154910_bb1620","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1152\/physrev.00045.2011","article-title":"Mechanisms of diabetic complications","volume":"93","author":"Forbes","year":"2013","journal-title":"Physiol Rev"},{"key":"10.1016\/j.metabol.2021.154910_bb1625","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/eurheartj\/ehl193","article-title":"EuroHeart failure survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population","volume":"27","author":"Nieminen","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.metabol.2021.154910_bb1630","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.289.2.194","article-title":"Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic","volume":"289","author":"Redfield","year":"2003","journal-title":"JAMA."},{"key":"10.1016\/j.metabol.2021.154910_bb1635","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jacc.2014.05.030","article-title":"Cardiovascular phenotype in HFpEF patients with or without diabetes: a RELAX trial ancillary study","volume":"64","author":"Lindman","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2021.154910_bb1640","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCULATIONAHA.107.728550","article-title":"Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension","volume":"117","author":"van Heerebeek","year":"2008","journal-title":"Circulation."},{"key":"10.1016\/j.metabol.2021.154910_bb1645","first-page":"632","article-title":"Heart failure with preserved ejection fraction in Diabetes: mechanisms and management","volume":"34","author":"Meagher","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.metabol.2021.154910_bb1650","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3389\/fcvm.2019.00015","article-title":"Microvascular rarefaction and heart failure with preserved ejection fraction","volume":"6","author":"Zeng","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.metabol.2021.154910_bb1655","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2021.154910_bb1660","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1093\/eurheartj\/ehv134","article-title":"Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes","volume":"36","author":"Seferovic","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.metabol.2021.154910_bb1665","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013114","article-title":"Association of Diabetes Mellitus on cardiac remodeling, quality of life, and clinical outcomes in heart failure with reduced and preserved ejection fraction","volume":"8","author":"Yap","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.metabol.2021.154910_bb1670","first-page":"1514","article-title":"Diabetic cardiomyopathy: current and future therapies","volume":"9","author":"Borghetti","year":"2018","journal-title":"Beyond Glycemic Control Front Physiol"},{"key":"10.1016\/j.metabol.2021.154910_bb1675","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1463-1326.2007.00803.x","article-title":"Diastolic dysfunction and abnormalities of the microcirculation in type 2 diabetes","volume":"10","author":"Brooks","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.metabol.2021.154910_bb1680","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.amjcard.2003.12.026","article-title":"Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus","volume":"93","author":"Boyer","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.metabol.2021.154910_bb1685","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jacc.2009.12.003","article-title":"The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction a population-based study","volume":"55","author":"From","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"575\u201399","key":"10.1016\/j.metabol.2021.154910_bb1690","first-page":"ix","article-title":"Diabetic cardiomyopathy","volume":"35","author":"Fonarow","year":"2006","journal-title":"Endocrinol Metab Clin N Am"},{"key":"10.1016\/j.metabol.2021.154910_bb1695","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.jacc.2006.07.033","article-title":"Diastolic dysfunction and diabetic cardiomyopathy: evaluation by Doppler echocardiography","volume":"48","author":"Galderisi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2021.154910_bb1700","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/CIRCULATIONAHA.110.937821","article-title":"Correlates of echocardiographic indices of cardiac remodeling over the adult life course: longitudinal observations from the Framingham heart study","volume":"122","author":"Cheng","year":"2010","journal-title":"Circulation."},{"key":"10.1016\/j.metabol.2021.154910_bb1705","first-page":"19","article-title":"Relationship of blood pressure and left ventricular mass to serum insulin levels in newly diagnosed non-insulin-dependent (type 2) diabetic patients and in non-diabetic subjects","volume":"4","author":"Uusitupa","year":"1987","journal-title":"Diabetes Res"},{"key":"10.1016\/j.metabol.2021.154910_bb1710","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.jacc.2013.01.053","article-title":"Insulin resistance, subclinical left ventricular remodeling, and the obesity paradox: MESA (multi-ethnic study of atherosclerosis)","volume":"61","author":"Shah","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2021.154910_bb1715","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ahj.2004.06.021","article-title":"Screening for heart disease in diabetic subjects","volume":"149","author":"Fang","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.metabol.2021.154910_bb1720","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12933-017-0506-x","article-title":"Diagnostic approaches for diabetic cardiomyopathy","volume":"16","author":"Lorenzo-Almor\u00f3s","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.metabol.2021.154910_bb1725","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/ehjci\/jey042","article-title":"Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI\/ASE\/industry task force to standardize deformation imaging","volume":"19","author":"Badano","year":"2018","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.metabol.2021.154910_bb1730","first-page":"18","article-title":"Non-invasive imaging in diabetic cardiomyopathy","volume":"6","author":"Mordi","year":"2019","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/j.metabol.2021.154910_bb1735","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.2009.476","article-title":"Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 Diabetes: the DIAD study: a randomized controlled trial","volume":"301","author":"Young","year":"2009","journal-title":"JAMA."},{"key":"10.1016\/j.metabol.2021.154910_bb1740","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/j.bbadis.2017.03.013","article-title":"Role of microRNA in diabetic cardiomyopathy: from mechanism to intervention","volume":"1863","author":"Guo","year":"2017","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"key":"10.1016\/j.metabol.2021.154910_bb1745","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3389\/fendo.2018.00300","article-title":"The big entity of new RNA world: long non-coding RNAs in microvascular complications of Diabetes","volume":"9","author":"Raut","year":"2018","journal-title":"Front Endocrinol"},{"issue":"3","key":"10.1016\/j.metabol.2021.154910_bb1750","first-page":"39","article-title":"Functional role of miR-155 in the pathogenesis of Diabetes mellitus and its complications","volume":"7","author":"Jankauskas","year":"2021","journal-title":"Noncoding RNA"},{"key":"10.1016\/j.metabol.2021.154910_bb1755","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2020.110944","article-title":"Value of circulating miRNA-21 in the diagnosis of subclinical diabetic cardiomyopathy","volume":"518","author":"Tao","year":"2020","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.metabol.2021.154910_bb1760","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s12265-018-9825-x","article-title":"The exosome: a new player in diabetic cardiomyopathy","volume":"12","author":"Tao","year":"2019","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.metabol.2021.154910_bb1765","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-981-10-4397-0_8","article-title":"Pathological effects of exosomes in mediating diabetic cardiomyopathy","volume":"998","author":"Salem","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.metabol.2021.154910_bb1770","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.yjmcc.2014.05.001","article-title":"Cardiomyocytes mediate anti-angiogenesis in type 2 diabetic rats through the exosomal transfer of miR-320 into endothelial cells","volume":"74","author":"Wang","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.metabol.2021.154910_bb1775","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1161\/CIRCULATIONAHA.106.679597","article-title":"Diabetic cardiomyopathy revisited","volume":"115","author":"Boudina","year":"2007","journal-title":"Circulation."},{"key":"10.1016\/j.metabol.2021.154910_bb1780","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00125-012-2694-y","article-title":"Type 2 diabetes and cardiovascular disease in women","volume":"56","author":"Norhammar","year":"2013","journal-title":"Diabetologia."},{"key":"10.1016\/j.metabol.2021.154910_bb1785","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1161\/CIRCULATIONAHA.108.815944","article-title":"Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the Framingham heart study of the national heart, lung, and blood institute","volume":"119","author":"Lee","year":"2009","journal-title":"Circulation."},{"key":"10.1016\/j.metabol.2021.154910_bb1790","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1056\/NEJM200101043440103","article-title":"The pathogenesis of acute pulmonary edema associated with hypertension","volume":"344","author":"Gandhi","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2021.154910_bb1795","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s004240000473","article-title":"Effects of gender on intracellular","volume":"441","author":"Curl","year":"2001","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.metabol.2021.154910_bb1800","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.yjmcc.2010.06.005","article-title":"Gender-related differences in ion-channel and transporter subunit expression in non-diseased human hearts","volume":"49","author":"Gaborit","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.metabol.2021.154910_bb1805","doi-asserted-by":"crossref","first-page":"H36","DOI":"10.1152\/ajpheart.00299.2010","article-title":"Sex differences in mechanisms of cardiac excitation-contraction coupling in rat ventricular myocytes","volume":"299","author":"Farrell","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.metabol.2021.154910_bb1810","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10142-009-0137-8","article-title":"Sex-dependent gene regulatory networks of the heart rhythm","volume":"10","author":"Iacobas","year":"2010","journal-title":"Funct Integr Genomics"},{"key":"10.1016\/j.metabol.2021.154910_bb1815","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111411","article-title":"Sex differences in beta-adrenergic responsiveness of action potentials and intracellular calcium handling in isolated rabbit hearts","volume":"9","author":"Hoeker","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2021.154910_bb1820","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00424-013-1233-0","article-title":"Sex differences in mechanisms of cardiac excitation-contraction coupling","volume":"465","author":"Parks","year":"2013","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.metabol.2021.154910_bb1825","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.568203","article-title":"Reciprocality between estrogen biology and calcium signaling in the cardiovascular system","volume":"11","author":"Tran","year":"2020","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.metabol.2021.154910_bb1830","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jacc.2011.09.054","article-title":"Transcriptome characterization of estrogen-treated human myocardium identifies myosin regulatory light chain interacting protein as a sex-specific element influencing contractile function","volume":"59","author":"Kararigas","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2021.154910_bb1835","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.abb.2012.12.023","article-title":"Sexually dimorphic myofilament function and cardiac troponin I phosphospecies distribution in hypertrophic cardiomyopathy mice","volume":"535","author":"McKee","year":"2013","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.metabol.2021.154910_bb1840","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13293-016-0084-8","article-title":"Male and female hypertrophic rat cardiac myocyte functional responses to ischemic stress and beta-adrenergic challenge are different","volume":"7","author":"Bell","year":"2016","journal-title":"Biol Sex Differ"},{"key":"10.1016\/j.metabol.2021.154910_bb1845","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.617902","article-title":"Sex disparities in cardiovascular risk factor assessment and screening for Diabetes-related complications in individuals with Diabetes: a systematic review","volume":"12","author":"de Jong","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.metabol.2021.154910_bb1850","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S0735-1097(98)00347-7","article-title":"Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload","volume":"32","author":"Douglas","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2021.154910_bb1855","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1042\/CS20150609","article-title":"Cardiomyocyte-specific overexpression of oestrogen receptor beta improves survival and cardiac function after myocardial infarction in female and male mice","volume":"130","author":"Schuster","year":"2016","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.metabol.2021.154910_bb1860","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00125-004-1448-x","article-title":"Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women\u2019s Health Initiative hormone trial","volume":"47","author":"Margolis","year":"2004","journal-title":"Diabetologia."},{"key":"10.1016\/j.metabol.2021.154910_bb1865","doi-asserted-by":"crossref","first-page":"H1584","DOI":"10.1152\/ajpheart.00420.2013","article-title":"Impact of sex on the heart\u2019s metabolic and functional responses to diabetic therapies","volume":"305","author":"Lyons","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.metabol.2021.154910_bb1870","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12933-017-0582-y","article-title":"Admission blood glucose and 10-year mortality among patients with or without pre-existing diabetes mellitus hospitalized with heart failure","volume":"16","author":"Itzhaki Ben Zadok","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.metabol.2021.154910_bb1875","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.3390\/ijms19102869","article-title":"Metabolic effects of metformin in the failing heart","volume":"19","author":"Dziubak","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2021.154910_bb1880","doi-asserted-by":"crossref","first-page":"e003643","DOI":"10.1161\/CIRCIMAGING.115.003643","article-title":"Impact of improved glycemic control on cardiac function in type 2 Diabetes mellitus","volume":"9","author":"Leung","year":"2016","journal-title":"Circ Cardiovasc Imag"},{"key":"10.1016\/j.metabol.2021.154910_bb1885","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00592-021-01705-x","article-title":"Evidence for human diabetic cardiomyopathy","volume":"58","author":"Marfella","year":"2021","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.metabol.2021.154910_bb1890","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/CIRCRESAHA.118.311371","article-title":"Heart failure in type 2 Diabetes mellitus","volume":"124","author":"Kenny","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2021.154910_bb1895","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.2337\/dc14-1720","article-title":"Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association","volume":"37","author":"de Ferranti","year":"2014","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.metabol.2021.154910_bb1900","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1093\/ehjcvp\/pvab039","article-title":"SGLT2 inhibitors in cardiovascular medicine","volume":"7","author":"Varzideh","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother."},{"key":"10.1016\/j.metabol.2021.154910_bb1905","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12872-021-02024-3","article-title":"Effects of empagliflozin in different phases of diabetes mellitus-related cardiomyopathy: a prospective observational study","volume":"21","author":"Oka","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.metabol.2021.154910_bb1910","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.119.042375","article-title":"Effect of Empagliflozin on left ventricular mass in patients with type 2 Diabetes mellitus and coronary artery disease","volume":"140","author":"Verma","year":"2019","journal-title":"Circulation."},{"issue":"16","key":"10.1016\/j.metabol.2021.154910_bb1915","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in Heart Failure with a Preserved Ejection","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2021.154910_bb1920","article-title":"Sodium glucose cotransporter 2 inhibitors reduce the risk of heart failure hospitalization in patients with type 2 Diabetes mellitus: A systematic review and Meta-analysis of randomized controlled trials","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.metabol.2021.154910_bb1925","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1111\/dom.13488","article-title":"Increases in circulating levels of ketone bodies and cardiovascular protection with SGLT2 inhibitors: is low-grade inflammation the neglected component?","volume":"20","author":"Prattichizzo","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.metabol.2021.154910_bb1930","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2021.154910_bb1935","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.2337\/db15-0084","article-title":"GLP-1 cleavage product reverses persistent ROS generation after transient hyperglycemia by disrupting an ROS-generating feedback loop","volume":"64","author":"Giacco","year":"2015","journal-title":"Diabetes."},{"issue":"7","key":"10.1016\/j.metabol.2021.154910_bb1940","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.3390\/cells9071621","article-title":"miR-7 regulates GLP-1-mediated insulin release by targeting beta-Arrestin 1","volume":"9","author":"Matarese","year":"2020","journal-title":"Cells."},{"key":"10.1016\/j.metabol.2021.154910_bb1945","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1161\/CIRCRESAHA.116.310119","article-title":"Why Don\u2019t we have proven treatments for HFpEF?","volume":"120","author":"Roh","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2021.154910_bb1950","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/HYPERTENSIONAHA.119.14057","article-title":"Medical therapies for heart failure with preserved ejection fraction","volume":"75","author":"Kjeldsen","year":"2020","journal-title":"Hypertension."},{"key":"10.1016\/j.metabol.2021.154910_bb1955","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/00325481.2020.1842620","article-title":"Heart failure with preserved ejection fraction: strategies for disease management and emerging therapeutic approaches","volume":"133","author":"Toth","year":"2021","journal-title":"Postgrad Med"},{"key":"10.1016\/j.metabol.2021.154910_bb1960","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00392-020-01633-w","article-title":"Therapeutic approaches in heart failure with preserved ejection fraction: past, present, and future","volume":"109","author":"Wintrich","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.metabol.2021.154910_bb1965","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-preserved trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2021.154910_bb1970","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/eurheartj\/ehq426","article-title":"Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment","volume":"32","author":"Borlaug","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.metabol.2021.154910_bb1975","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3389\/fcvm.2019.00111","article-title":"Devices in heart failure patients-who benefits from ICD and CRT?","volume":"6","author":"Breitenstein","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.metabol.2021.154910_bb1980","first-page":"6","article-title":"Implantable cardioverter-defibrillators for secondary prevention of sudden cardiac death: a review","author":"Borne","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.metabol.2021.154910_bb1985","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1177\/1559827617695219","article-title":"Heart failure with preserved ejection fraction: prevention and management","volume":"13","author":"Cilia","year":"2019","journal-title":"Am J Lifestyle Med"},{"key":"10.1016\/j.metabol.2021.154910_bb1990","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1161\/CIRCHEARTFAILURE.114.001615","article-title":"Exercise training in patients with heart failure and preserved ejection fraction","volume":"8","author":"Pandey","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.metabol.2021.154910_bb1995","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3389\/fendo.2018.00729","article-title":"Physical exercise and its protective effects on diabetic cardiomyopathy: what is the evidence?","volume":"9","author":"Zheng","year":"2018","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.metabol.2021.154910_bb2000","first-page":"In press","article-title":"Cardiovascular endocrinology: evolving concepts and updated epidemiology of relevant diseases","author":"Varzideh","year":"2021","journal-title":"Front Endocrinol"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049521002109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049521002109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:28:48Z","timestamp":1758428928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049521002109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":400,"alternative-id":["S0026049521002109"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2021.154910","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heart failure in diabetes","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2021.154910","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154910"}}